Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker.
Bristol Myers Squibb Company inked a pair of technology collaborations on 4 October, with San Francisco protein degradation specialist...